PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
hoxb6a
|
ENSDARG00000010630 | homeobox B6a |
hoxb6b
|
ENSDARG00000026513 | homeobox B6b |
hoxb6b
|
ENSDARG00000111786 | homeobox B6b |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
hoxb6b | dr11_v1_chr12_+_27127139_27127139 | 0.51 | 1.1e-07 | Click! |
hoxb6a | dr11_v1_chr3_+_23703704_23703704 | 0.23 | 2.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_25916530 | 78.82 |
ENSDART00000186386
|
sncgb
|
synuclein, gamma b (breast cancer-specific protein 1) |
chr8_-_49431939 | 75.54 |
ENSDART00000011453
ENSDART00000088240 ENSDART00000114173 |
sypb
|
synaptophysin b |
chr9_-_32753535 | 68.04 |
ENSDART00000060006
|
olig2
|
oligodendrocyte lineage transcription factor 2 |
chr20_+_34915945 | 66.28 |
ENSDART00000153064
|
snap25a
|
synaptosomal-associated protein, 25a |
chr2_-_54387550 | 62.83 |
ENSDART00000097388
|
napgb
|
N-ethylmaleimide-sensitive factor attachment protein, gamma b |
chr10_-_17745345 | 61.74 |
ENSDART00000132690
ENSDART00000135376 |
si:dkey-200l5.4
|
si:dkey-200l5.4 |
chr21_-_21373242 | 57.87 |
ENSDART00000079629
|
ppm1nb
|
protein phosphatase, Mg2+/Mn2+ dependent, 1Nb (putative) |
chr22_-_13851297 | 57.34 |
ENSDART00000080306
|
s100b
|
S100 calcium binding protein, beta (neural) |
chr4_-_7212875 | 57.06 |
ENSDART00000161297
|
lrrn3b
|
leucine rich repeat neuronal 3b |
chr5_-_29643930 | 56.90 |
ENSDART00000161250
|
grin1b
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1b |
chr14_+_35748385 | 56.73 |
ENSDART00000064617
ENSDART00000074671 ENSDART00000172803 |
gria2b
|
glutamate receptor, ionotropic, AMPA 2b |
chr21_-_22114625 | 54.81 |
ENSDART00000177426
ENSDART00000135410 |
elmod1
|
ELMO/CED-12 domain containing 1 |
chr11_+_25735478 | 53.79 |
ENSDART00000103566
|
si:dkey-183j2.10
|
si:dkey-183j2.10 |
chr9_+_31282161 | 52.33 |
ENSDART00000010774
|
zic2a
|
zic family member 2 (odd-paired homolog, Drosophila), a |
chr21_-_22115136 | 51.58 |
ENSDART00000134715
ENSDART00000089246 ENSDART00000139789 |
elmod1
|
ELMO/CED-12 domain containing 1 |
chr24_-_6158933 | 50.73 |
ENSDART00000021609
|
gad2
|
glutamate decarboxylase 2 |
chr5_+_58372164 | 50.73 |
ENSDART00000057910
|
nrgna
|
neurogranin (protein kinase C substrate, RC3) a |
chr21_+_13861589 | 48.99 |
ENSDART00000015629
ENSDART00000171306 |
stxbp1a
|
syntaxin binding protein 1a |
chr22_+_18389271 | 47.99 |
ENSDART00000088270
|
yjefn3
|
YjeF N-terminal domain containing 3 |
chr14_+_35748206 | 47.63 |
ENSDART00000177391
|
gria2b
|
glutamate receptor, ionotropic, AMPA 2b |
chr16_-_16182319 | 47.48 |
ENSDART00000103815
|
stmn2a
|
stathmin 2a |
chr23_-_11870962 | 47.42 |
ENSDART00000143481
|
si:dkey-178k16.1
|
si:dkey-178k16.1 |
chr9_-_44295071 | 47.35 |
ENSDART00000011837
|
neurod1
|
neuronal differentiation 1 |
chr13_+_36764715 | 46.30 |
ENSDART00000111832
ENSDART00000085230 |
atl1
|
atlastin GTPase 1 |
chr4_+_5506952 | 46.06 |
ENSDART00000032857
ENSDART00000160222 |
mapk11
|
mitogen-activated protein kinase 11 |
chr23_-_30431333 | 45.79 |
ENSDART00000146633
|
camta1a
|
calmodulin binding transcription activator 1a |
chr10_+_21804772 | 45.35 |
ENSDART00000162194
|
pcdh1g31
|
protocadherin 1 gamma 31 |
chr20_-_34801181 | 45.32 |
ENSDART00000048375
ENSDART00000132426 |
stmn4
|
stathmin-like 4 |
chr4_+_12615836 | 44.84 |
ENSDART00000003583
|
lmo3
|
LIM domain only 3 |
chr15_+_43166511 | 44.64 |
ENSDART00000011737
|
flj13639
|
flj13639 |
chr4_+_11375894 | 44.24 |
ENSDART00000190471
ENSDART00000143963 |
pcloa
|
piccolo presynaptic cytomatrix protein a |
chr14_+_34966598 | 44.06 |
ENSDART00000004550
|
rnf145a
|
ring finger protein 145a |
chr9_-_54840124 | 44.01 |
ENSDART00000137214
ENSDART00000085693 |
gpm6bb
|
glycoprotein M6Bb |
chr20_-_25671342 | 43.91 |
ENSDART00000182775
|
si:dkeyp-117h8.2
|
si:dkeyp-117h8.2 |
chr21_-_42007213 | 43.82 |
ENSDART00000188804
ENSDART00000092821 ENSDART00000165743 |
gabrg2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
chr13_+_11436130 | 43.67 |
ENSDART00000169895
|
zbtb18
|
zinc finger and BTB domain containing 18 |
chr15_-_44512461 | 43.57 |
ENSDART00000155456
|
gria4a
|
glutamate receptor, ionotropic, AMPA 4a |
chr17_-_16965809 | 43.30 |
ENSDART00000153697
|
nrxn3a
|
neurexin 3a |
chr8_+_31248917 | 43.04 |
ENSDART00000112170
|
unm_hu7912
|
un-named hu7912 |
chr1_-_14234076 | 42.76 |
ENSDART00000040049
|
camk2d2
|
calcium/calmodulin-dependent protein kinase (CaM kinase) II delta 2 |
chr17_-_26926577 | 42.64 |
ENSDART00000050202
|
rcan3
|
regulator of calcineurin 3 |
chr12_+_24344963 | 42.01 |
ENSDART00000191648
ENSDART00000183180 ENSDART00000088178 ENSDART00000189696 |
nrxn1a
|
neurexin 1a |
chr14_+_35806605 | 41.91 |
ENSDART00000173093
|
gria2b
|
glutamate receptor, ionotropic, AMPA 2b |
chr2_+_31833997 | 41.76 |
ENSDART00000066788
|
epdr1
|
ependymin related 1 |
chr14_-_36378494 | 41.75 |
ENSDART00000058503
|
gpm6aa
|
glycoprotein M6Aa |
chr19_-_9472893 | 41.55 |
ENSDART00000045565
ENSDART00000137505 |
vamp1
|
vesicle-associated membrane protein 1 |
chr21_+_28958471 | 41.12 |
ENSDART00000144331
ENSDART00000005929 |
ppp3ca
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr6_-_10320676 | 40.97 |
ENSDART00000151247
|
scn1lab
|
sodium channel, voltage-gated, type I like, alpha b |
chr24_-_24849091 | 40.68 |
ENSDART00000133649
ENSDART00000038290 |
crhb
|
corticotropin releasing hormone b |
chr13_+_27314795 | 40.59 |
ENSDART00000128726
|
eef1a1a
|
eukaryotic translation elongation factor 1 alpha 1a |
chr8_+_31119548 | 40.36 |
ENSDART00000136578
|
syn1
|
synapsin I |
chr1_+_25801648 | 39.98 |
ENSDART00000129471
|
gucy1b1
|
guanylate cyclase 1 soluble subunit beta 1 |
chr5_+_64732036 | 39.96 |
ENSDART00000073950
|
olfm1a
|
olfactomedin 1a |
chr2_+_34967022 | 39.60 |
ENSDART00000134926
|
astn1
|
astrotactin 1 |
chr10_-_22845485 | 39.51 |
ENSDART00000079454
|
vamp2
|
vesicle-associated membrane protein 2 |
chr20_+_34717403 | 39.39 |
ENSDART00000034252
|
pnocb
|
prepronociceptin b |
chr7_-_49594995 | 39.17 |
ENSDART00000174161
ENSDART00000109147 |
brsk2b
|
BR serine/threonine kinase 2b |
chr20_+_27020201 | 38.94 |
ENSDART00000126919
ENSDART00000016014 |
chga
|
chromogranin A |
chr5_-_23362602 | 38.82 |
ENSDART00000137120
|
gria3a
|
glutamate receptor, ionotropic, AMPA 3a |
chr12_-_10300101 | 38.71 |
ENSDART00000126428
|
mpp2b
|
membrane protein, palmitoylated 2b (MAGUK p55 subfamily member 2) |
chr24_-_15648636 | 38.42 |
ENSDART00000136200
|
cbln2b
|
cerebellin 2b precursor |
chr23_+_20563779 | 38.37 |
ENSDART00000146008
|
camkvl
|
CaM kinase-like vesicle-associated, like |
chr25_-_13381854 | 38.36 |
ENSDART00000164621
ENSDART00000169129 |
ndrg4
|
NDRG family member 4 |
chr16_+_37582872 | 38.33 |
ENSDART00000169331
|
adgrb1a
|
adhesion G protein-coupled receptor B1a |
chr17_-_12389259 | 38.31 |
ENSDART00000185724
|
snap25b
|
synaptosomal-associated protein, 25b |
chr22_-_11493236 | 38.18 |
ENSDART00000002691
|
tspan7b
|
tetraspanin 7b |
chr8_-_34052019 | 38.17 |
ENSDART00000040126
ENSDART00000159208 ENSDART00000048994 ENSDART00000098822 |
pbx3b
|
pre-B-cell leukemia homeobox 3b |
chr18_-_38088099 | 37.78 |
ENSDART00000146120
|
luzp2
|
leucine zipper protein 2 |
chr6_+_3828560 | 37.30 |
ENSDART00000185273
ENSDART00000179091 |
gad1b
|
glutamate decarboxylase 1b |
chr24_-_33756003 | 37.10 |
ENSDART00000079283
|
tmeff1b
|
transmembrane protein with EGF-like and two follistatin-like domains 1b |
chr15_-_24869826 | 37.08 |
ENSDART00000127047
|
tusc5a
|
tumor suppressor candidate 5a |
chr15_+_22267847 | 37.05 |
ENSDART00000110665
|
spa17
|
sperm autoantigenic protein 17 |
chr16_-_12173554 | 36.97 |
ENSDART00000110567
ENSDART00000155935 |
clstn3
|
calsyntenin 3 |
chr11_+_35364445 | 36.87 |
ENSDART00000125766
|
camkvb
|
CaM kinase-like vesicle-associated b |
chr5_-_23280098 | 36.80 |
ENSDART00000126540
ENSDART00000051533 |
plp1b
|
proteolipid protein 1b |
chr7_-_45076131 | 36.66 |
ENSDART00000110590
|
zgc:194678
|
zgc:194678 |
chr3_-_28665291 | 36.46 |
ENSDART00000151670
|
fbxl16
|
F-box and leucine-rich repeat protein 16 |
chr7_+_25059845 | 36.45 |
ENSDART00000077215
|
ppp2r5b
|
protein phosphatase 2, regulatory subunit B', beta |
chr21_+_22630297 | 36.44 |
ENSDART00000147175
|
si:dkeyp-69c1.7
|
si:dkeyp-69c1.7 |
chr19_+_10396042 | 36.19 |
ENSDART00000028048
ENSDART00000151735 |
necap1
|
NECAP endocytosis associated 1 |
chr24_+_2519761 | 35.82 |
ENSDART00000106619
|
nrn1a
|
neuritin 1a |
chr13_+_27951688 | 35.68 |
ENSDART00000050303
|
b3gat2
|
beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S) |
chr13_-_29420885 | 35.63 |
ENSDART00000024225
|
chata
|
choline O-acetyltransferase a |
chr16_-_26074529 | 35.56 |
ENSDART00000148653
ENSDART00000148923 |
tmem145
|
transmembrane protein 145 |
chr10_+_21576909 | 35.26 |
ENSDART00000168604
ENSDART00000166533 |
pcdh1a3
|
protocadherin 1 alpha 3 |
chr25_-_32869794 | 35.23 |
ENSDART00000162784
|
tmem266
|
transmembrane protein 266 |
chr6_-_41229787 | 35.18 |
ENSDART00000065013
|
synpr
|
synaptoporin |
chr14_-_32258759 | 35.13 |
ENSDART00000052949
|
fgf13a
|
fibroblast growth factor 13a |
chr20_-_45661049 | 35.06 |
ENSDART00000124582
ENSDART00000131251 |
napbb
|
N-ethylmaleimide-sensitive factor attachment protein, beta b |
chr3_+_54047342 | 34.92 |
ENSDART00000178486
|
olfm2a
|
olfactomedin 2a |
chr8_-_14052349 | 34.42 |
ENSDART00000135811
|
atp2b3a
|
ATPase plasma membrane Ca2+ transporting 3a |
chr17_+_33495194 | 34.40 |
ENSDART00000033691
|
pth2
|
parathyroid hormone 2 |
chr20_-_29474859 | 34.31 |
ENSDART00000152906
ENSDART00000045249 |
scg5
|
secretogranin V |
chr15_-_12545683 | 34.29 |
ENSDART00000162807
|
scn2b
|
sodium channel, voltage-gated, type II, beta |
chr7_-_35708450 | 33.98 |
ENSDART00000193886
|
irx5a
|
iroquois homeobox 5a |
chr7_-_31932723 | 33.90 |
ENSDART00000014843
|
bdnf
|
brain-derived neurotrophic factor |
chr3_-_18711288 | 33.89 |
ENSDART00000183885
|
grid2ipa
|
glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein, a |
chr7_-_52842605 | 33.86 |
ENSDART00000083002
|
map1aa
|
microtubule-associated protein 1Aa |
chr17_-_37214196 | 33.79 |
ENSDART00000128715
|
kif3cb
|
kinesin family member 3Cb |
chr8_+_47633438 | 33.71 |
ENSDART00000139096
|
si:ch211-251b21.1
|
si:ch211-251b21.1 |
chr14_-_18672561 | 33.68 |
ENSDART00000166730
ENSDART00000006998 |
slitrk4
|
SLIT and NTRK-like family, member 4 |
chr20_+_30490682 | 33.67 |
ENSDART00000184871
|
myt1la
|
myelin transcription factor 1-like, a |
chr6_-_35472923 | 33.43 |
ENSDART00000185907
|
rgs8
|
regulator of G protein signaling 8 |
chr16_-_25519762 | 33.35 |
ENSDART00000146479
ENSDART00000142062 |
dtnbp1a
|
dystrobrevin binding protein 1a |
chr19_+_24882845 | 33.32 |
ENSDART00000010580
|
si:ch211-195b13.1
|
si:ch211-195b13.1 |
chr7_+_30787903 | 33.30 |
ENSDART00000174000
|
apba2b
|
amyloid beta (A4) precursor protein-binding, family A, member 2b |
chr23_+_28693278 | 33.24 |
ENSDART00000078148
|
smc1a
|
structural maintenance of chromosomes 1A |
chr16_+_46111849 | 32.87 |
ENSDART00000172232
|
sv2a
|
synaptic vesicle glycoprotein 2A |
chr14_-_49063157 | 32.87 |
ENSDART00000021260
|
sept8b
|
septin 8b |
chr6_+_24817852 | 32.79 |
ENSDART00000165609
|
barhl2
|
BarH-like homeobox 2 |
chr6_+_29860776 | 32.57 |
ENSDART00000028406
|
dlg1
|
discs, large homolog 1 (Drosophila) |
chr15_-_27710513 | 32.33 |
ENSDART00000005641
ENSDART00000134373 |
lhx1a
|
LIM homeobox 1a |
chr12_+_18681477 | 32.25 |
ENSDART00000127981
ENSDART00000143979 |
rgs9b
|
regulator of G protein signaling 9b |
chr11_+_39672874 | 32.14 |
ENSDART00000046663
ENSDART00000157659 |
camta1b
|
calmodulin binding transcription activator 1b |
chr17_-_36936649 | 32.11 |
ENSDART00000145236
|
dpysl5a
|
dihydropyrimidinase-like 5a |
chr17_+_5915875 | 32.11 |
ENSDART00000184179
|
fndc4b
|
fibronectin type III domain containing 4b |
chr7_-_28148310 | 32.10 |
ENSDART00000044208
|
lmo1
|
LIM domain only 1 |
chr24_-_8730913 | 31.97 |
ENSDART00000187228
ENSDART00000082349 ENSDART00000186660 |
tfap2a
|
transcription factor AP-2 alpha |
chr1_+_45085194 | 31.91 |
ENSDART00000193863
|
si:ch211-151p13.8
|
si:ch211-151p13.8 |
chr13_+_11440389 | 31.91 |
ENSDART00000186463
|
zbtb18
|
zinc finger and BTB domain containing 18 |
chr14_+_44545092 | 31.82 |
ENSDART00000175454
|
lingo2a
|
leucine rich repeat and Ig domain containing 2a |
chr10_+_15777258 | 31.79 |
ENSDART00000140511
|
apba1b
|
amyloid beta (A4) precursor protein-binding, family A, member 1b |
chr10_+_21650828 | 31.75 |
ENSDART00000160754
|
pcdh1g1
|
protocadherin 1 gamma 1 |
chr8_+_16025554 | 31.63 |
ENSDART00000110171
|
elavl4
|
ELAV like neuron-specific RNA binding protein 4 |
chr21_-_42007482 | 31.55 |
ENSDART00000075740
|
gabrg2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
chr1_-_26782573 | 31.54 |
ENSDART00000090611
|
sh3gl2a
|
SH3 domain containing GRB2 like 2a, endophilin A1 |
chr18_-_8313686 | 31.52 |
ENSDART00000182187
|
mapk8ip2
|
mitogen-activated protein kinase 8 interacting protein 2 |
chr1_+_16397063 | 31.49 |
ENSDART00000159794
|
micu3a
|
mitochondrial calcium uptake family, member 3a |
chr21_-_27010796 | 31.43 |
ENSDART00000065398
ENSDART00000144342 ENSDART00000126542 |
ppp1r14ba
|
protein phosphatase 1, regulatory (inhibitor) subunit 14Ba |
chr2_+_34967210 | 31.34 |
ENSDART00000141796
|
astn1
|
astrotactin 1 |
chr17_-_37156520 | 31.34 |
ENSDART00000145669
|
dtnbb
|
dystrobrevin, beta b |
chr24_-_7699356 | 31.16 |
ENSDART00000013117
|
syt5b
|
synaptotagmin Vb |
chr7_+_61050329 | 31.16 |
ENSDART00000115355
|
nwd2
|
NACHT and WD repeat domain containing 2 |
chr1_-_56223913 | 31.14 |
ENSDART00000019573
|
zgc:65894
|
zgc:65894 |
chr22_+_5103349 | 31.00 |
ENSDART00000083474
|
atcaya
|
ataxia, cerebellar, Cayman type a |
chr4_-_5302866 | 30.98 |
ENSDART00000138590
|
SNAP91 (1 of many)
|
si:ch211-214j24.9 |
chr10_+_29698467 | 30.92 |
ENSDART00000163402
|
dlg2
|
discs, large homolog 2 (Drosophila) |
chr3_+_29714775 | 30.90 |
ENSDART00000041388
|
cacng2a
|
calcium channel, voltage-dependent, gamma subunit 2a |
chr8_+_22582146 | 30.66 |
ENSDART00000157655
ENSDART00000189892 |
CT583651.2
|
|
chr20_-_20821783 | 30.66 |
ENSDART00000152577
ENSDART00000027603 ENSDART00000145601 |
ckbb
|
creatine kinase, brain b |
chr25_+_7670683 | 30.64 |
ENSDART00000040275
|
kcnj11l
|
potassium inwardly-rectifying channel, subfamily J, member 11, like |
chr12_+_5081759 | 30.51 |
ENSDART00000164178
|
prrt2
|
proline-rich transmembrane protein 2 |
chr10_+_21563986 | 30.37 |
ENSDART00000100600
|
pcdh1a6
|
protocadherin 1 alpha 6 |
chr19_-_31522625 | 30.37 |
ENSDART00000158438
ENSDART00000035049 |
necab1
|
N-terminal EF-hand calcium binding protein 1 |
chr3_-_28075756 | 30.13 |
ENSDART00000122037
|
rbfox1
|
RNA binding fox-1 homolog 1 |
chr15_+_36115955 | 30.01 |
ENSDART00000032702
|
sst1.2
|
somatostatin 1, tandem duplicate 2 |
chr9_+_44430974 | 29.97 |
ENSDART00000056846
|
ppp1r1c
|
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
chr6_-_46398584 | 29.82 |
ENSDART00000193098
|
camk1a
|
calcium/calmodulin-dependent protein kinase Ia |
chr21_-_43949208 | 29.67 |
ENSDART00000150983
|
camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr14_-_43000836 | 29.63 |
ENSDART00000162714
|
pcdh10b
|
protocadherin 10b |
chr1_-_22412042 | 29.60 |
ENSDART00000074678
|
chrnb3a
|
cholinergic receptor, nicotinic, beta polypeptide 3a |
chr13_+_38430466 | 29.52 |
ENSDART00000132691
|
adgrb3
|
adhesion G protein-coupled receptor B3 |
chr20_-_28800999 | 29.30 |
ENSDART00000049462
|
rab15
|
RAB15, member RAS oncogene family |
chr13_+_16522608 | 29.11 |
ENSDART00000182838
ENSDART00000143200 |
kcnma1a
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a |
chr17_+_31185276 | 29.08 |
ENSDART00000062887
|
disp2
|
dispatched homolog 2 (Drosophila) |
chr1_+_25783801 | 28.92 |
ENSDART00000102455
|
gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr14_-_34044369 | 28.79 |
ENSDART00000149396
ENSDART00000123607 ENSDART00000190746 |
cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr3_-_32320537 | 28.77 |
ENSDART00000113550
ENSDART00000168483 |
si:dkey-16p21.7
|
si:dkey-16p21.7 |
chr19_+_14921000 | 28.75 |
ENSDART00000144052
|
oprd1a
|
opioid receptor, delta 1a |
chr6_-_38419318 | 28.73 |
ENSDART00000138026
|
gabra5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
chr4_-_193762 | 28.69 |
ENSDART00000169667
|
ptpro
|
protein tyrosine phosphatase, receptor type, O |
chr1_+_34203817 | 28.60 |
ENSDART00000191432
ENSDART00000046094 |
arl6
|
ADP-ribosylation factor-like 6 |
chr6_-_24358732 | 28.46 |
ENSDART00000159595
|
ephx4
|
epoxide hydrolase 4 |
chr1_-_23557877 | 28.45 |
ENSDART00000145942
|
fam184b
|
family with sequence similarity 184, member B |
chr17_-_45552602 | 28.45 |
ENSDART00000154844
ENSDART00000034432 |
susd4
|
sushi domain containing 4 |
chr21_-_39639954 | 28.44 |
ENSDART00000026766
|
aldocb
|
aldolase C, fructose-bisphosphate, b |
chr4_+_17279966 | 28.37 |
ENSDART00000067005
ENSDART00000137487 |
bcat1
|
branched chain amino-acid transaminase 1, cytosolic |
chr23_-_29667716 | 28.35 |
ENSDART00000158302
ENSDART00000133902 |
clstn1
|
calsyntenin 1 |
chr3_-_28120092 | 28.34 |
ENSDART00000151143
|
rbfox1
|
RNA binding fox-1 homolog 1 |
chr17_-_22010668 | 28.31 |
ENSDART00000031998
|
slc22a7b.1
|
solute carrier family 22 (organic anion transporter), member 7b, tandem duplicate 1 |
chr10_-_24371312 | 28.31 |
ENSDART00000149362
|
pitpnab
|
phosphatidylinositol transfer protein, alpha b |
chr1_-_38815361 | 28.23 |
ENSDART00000148790
ENSDART00000148572 ENSDART00000149080 |
asb5b
|
ankyrin repeat and SOCS box containing 5b |
chr1_+_40023640 | 28.22 |
ENSDART00000101623
|
lgi2b
|
leucine-rich repeat LGI family, member 2b |
chr2_+_24199276 | 28.19 |
ENSDART00000140575
|
map4l
|
microtubule associated protein 4 like |
chr14_-_34276574 | 28.02 |
ENSDART00000021437
|
gria1a
|
glutamate receptor, ionotropic, AMPA 1a |
chr5_-_32323136 | 27.86 |
ENSDART00000110804
|
hspb15
|
heat shock protein, alpha-crystallin-related, b15 |
chr1_+_11977426 | 27.85 |
ENSDART00000103399
|
tspan5b
|
tetraspanin 5b |
chr5_-_3627110 | 27.71 |
ENSDART00000156071
|
si:zfos-375h5.1
|
si:zfos-375h5.1 |
chr20_-_10120442 | 27.67 |
ENSDART00000144970
|
meis2b
|
Meis homeobox 2b |
chr23_-_14918276 | 27.64 |
ENSDART00000179831
|
ndrg3b
|
ndrg family member 3b |
chr9_-_1702648 | 27.63 |
ENSDART00000102934
|
hnrnpa3
|
heterogeneous nuclear ribonucleoprotein A3 |
chr13_+_7292061 | 27.54 |
ENSDART00000179504
|
CABZ01072077.1
|
Danio rerio neuroblast differentiation-associated protein AHNAK-like (LOC795051), mRNA. |
chr19_-_32641725 | 27.40 |
ENSDART00000165006
ENSDART00000188185 |
hpca
|
hippocalcin |
chr3_+_46628885 | 27.33 |
ENSDART00000006602
|
pde4a
|
phosphodiesterase 4A, cAMP-specific |
chr24_+_14713776 | 27.33 |
ENSDART00000134475
|
gdap1
|
ganglioside induced differentiation associated protein 1 |
chr1_+_7679328 | 27.14 |
ENSDART00000163488
ENSDART00000190070 |
en1b
|
engrailed homeobox 1b |
chr2_+_24199073 | 27.12 |
ENSDART00000144110
|
map4l
|
microtubule associated protein 4 like |
chr23_-_29505463 | 27.10 |
ENSDART00000050915
|
kif1b
|
kinesin family member 1B |
chr21_-_30545121 | 27.10 |
ENSDART00000019199
|
rab39ba
|
RAB39B, member RAS oncogene family a |
chr13_-_33000649 | 27.08 |
ENSDART00000133677
|
rbm25a
|
RNA binding motif protein 25a |
chr16_-_20435475 | 27.00 |
ENSDART00000139776
|
chn2
|
chimerin 2 |
chr20_+_16743056 | 26.99 |
ENSDART00000050308
|
calm1b
|
calmodulin 1b |
chr19_-_17658160 | 26.88 |
ENSDART00000151766
ENSDART00000170790 ENSDART00000186678 ENSDART00000188045 ENSDART00000176980 ENSDART00000166313 ENSDART00000188589 |
thrb
|
thyroid hormone receptor beta |
chr14_-_33872092 | 26.77 |
ENSDART00000111903
|
si:ch73-335m24.2
|
si:ch73-335m24.2 |
chr10_+_21588002 | 26.63 |
ENSDART00000100596
|
pcdh1a6
|
protocadherin 1 alpha 6 |
chr10_+_21559605 | 26.58 |
ENSDART00000123648
ENSDART00000108584 |
pcdh1a3
pcdh1a3
|
protocadherin 1 alpha 3 protocadherin 1 alpha 3 |
chr20_-_26042070 | 26.53 |
ENSDART00000140255
|
si:dkey-12h9.6
|
si:dkey-12h9.6 |
chr16_+_32059785 | 26.50 |
ENSDART00000134459
|
si:dkey-40m6.8
|
si:dkey-40m6.8 |
chr12_+_24344611 | 26.18 |
ENSDART00000093094
|
nrxn1a
|
neurexin 1a |
chr14_-_2264494 | 25.90 |
ENSDART00000191149
|
pcdh2ab9
|
protocadherin 2 alpha b 9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.3 | 88.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
24.4 | 121.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
17.0 | 68.0 | GO:0021742 | abducens nucleus development(GO:0021742) |
16.3 | 146.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
16.2 | 32.3 | GO:0061213 | regulation of morphogenesis of a branching structure(GO:0060688) positive regulation of mesonephros development(GO:0061213) regulation of mesonephros development(GO:0061217) regulation of kidney development(GO:0090183) positive regulation of kidney development(GO:0090184) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
14.7 | 44.0 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) negative regulation of anion transport(GO:1903792) |
14.6 | 43.9 | GO:0048917 | posterior lateral line ganglion development(GO:0048917) |
14.4 | 143.7 | GO:1904071 | presynaptic active zone assembly(GO:1904071) |
13.7 | 41.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
13.6 | 40.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
13.5 | 53.8 | GO:0060155 | secretory granule organization(GO:0033363) platelet dense granule organization(GO:0060155) |
13.0 | 38.9 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) negative regulation of peptide hormone secretion(GO:0090278) |
12.3 | 37.0 | GO:0021611 | facial nerve formation(GO:0021611) |
12.0 | 48.0 | GO:0010874 | regulation of cholesterol efflux(GO:0010874) |
11.9 | 35.6 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
11.4 | 45.5 | GO:0009098 | leucine biosynthetic process(GO:0009098) |
11.1 | 55.3 | GO:0016322 | neuron remodeling(GO:0016322) |
10.9 | 43.6 | GO:0060074 | synapse maturation(GO:0060074) |
10.2 | 10.2 | GO:0032652 | interleukin-1 production(GO:0032612) regulation of interleukin-1 production(GO:0032652) |
10.0 | 40.0 | GO:0099543 | trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
9.5 | 28.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
8.8 | 35.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
8.4 | 33.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
8.3 | 50.0 | GO:0021767 | mammillary body development(GO:0021767) |
8.3 | 24.8 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
8.2 | 8.2 | GO:0060031 | mediolateral intercalation(GO:0060031) |
8.2 | 32.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
8.1 | 24.2 | GO:0021530 | spinal cord oligodendrocyte cell fate specification(GO:0021530) |
7.6 | 22.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
7.5 | 15.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
7.5 | 52.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
7.3 | 132.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
7.1 | 21.3 | GO:1901232 | regulation of convergent extension involved in axis elongation(GO:1901232) positive regulation of epiboly involved in gastrulation with mouth forming second(GO:1904088) |
6.9 | 34.3 | GO:0061072 | iris morphogenesis(GO:0061072) |
6.7 | 20.2 | GO:0042416 | dopamine biosynthetic process from tyrosine(GO:0006585) dopamine biosynthetic process(GO:0042416) |
6.3 | 143.9 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
6.0 | 24.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
6.0 | 18.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
5.9 | 11.8 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
5.8 | 52.4 | GO:0060118 | vestibular receptor cell differentiation(GO:0060114) vestibular receptor cell development(GO:0060118) |
5.7 | 23.0 | GO:0046166 | methylglyoxal biosynthetic process(GO:0019242) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
5.7 | 11.5 | GO:0051196 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
5.7 | 102.1 | GO:0072160 | pronephric nephron tubule epithelial cell differentiation(GO:0035778) cell differentiation involved in pronephros development(GO:0039014) nephron tubule epithelial cell differentiation(GO:0072160) |
5.7 | 17.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
5.5 | 149.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
5.4 | 32.4 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
5.3 | 63.9 | GO:0035094 | response to nicotine(GO:0035094) |
5.1 | 15.4 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
5.1 | 15.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
4.9 | 34.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
4.8 | 67.8 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
4.8 | 38.5 | GO:0021794 | thalamus development(GO:0021794) |
4.8 | 24.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
4.8 | 14.4 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
4.8 | 71.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
4.5 | 13.5 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
4.5 | 13.4 | GO:0031642 | negative regulation of myelination(GO:0031642) negative regulation of neurological system process(GO:0031645) |
4.5 | 71.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
4.4 | 40.0 | GO:0061075 | positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) |
4.4 | 35.5 | GO:0006543 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
4.4 | 39.9 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
4.4 | 79.3 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
4.4 | 13.2 | GO:0060986 | regulation of endocrine process(GO:0044060) endocrine hormone secretion(GO:0060986) |
4.4 | 79.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
4.4 | 43.7 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
4.3 | 30.4 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
4.3 | 17.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.3 | 13.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) positive regulation of endoplasmic reticulum tubular network organization(GO:1903373) |
4.3 | 30.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
4.3 | 17.1 | GO:0046552 | retinal cone cell fate determination(GO:0042671) eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate determination(GO:0043703) retinal cone cell fate commitment(GO:0046551) photoreceptor cell fate commitment(GO:0046552) camera-type eye photoreceptor cell fate commitment(GO:0060220) |
4.1 | 53.5 | GO:0046314 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
4.1 | 12.3 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
4.0 | 16.0 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
4.0 | 23.9 | GO:0003232 | bulbus arteriosus development(GO:0003232) |
4.0 | 31.9 | GO:0032889 | regulation of vacuole fusion, non-autophagic(GO:0032889) |
4.0 | 43.8 | GO:0006798 | polyphosphate metabolic process(GO:0006797) polyphosphate catabolic process(GO:0006798) |
4.0 | 71.4 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) |
3.9 | 74.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
3.8 | 15.3 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) electron transport coupled proton transport(GO:0015990) |
3.8 | 26.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
3.8 | 26.7 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
3.7 | 29.7 | GO:0021553 | olfactory nerve development(GO:0021553) olfactory nerve morphogenesis(GO:0021627) olfactory nerve formation(GO:0021628) |
3.7 | 44.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) positive regulation of vesicle fusion(GO:0031340) |
3.7 | 25.9 | GO:0010996 | response to auditory stimulus(GO:0010996) |
3.7 | 59.1 | GO:0048923 | posterior lateral line neuromast hair cell differentiation(GO:0048923) |
3.6 | 17.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
3.5 | 170.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
3.5 | 28.2 | GO:0043092 | amino acid import(GO:0043090) L-amino acid import(GO:0043092) |
3.4 | 82.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
3.4 | 16.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) protein localization to axon(GO:0099612) |
3.3 | 23.4 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
3.3 | 36.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.3 | 13.3 | GO:0010226 | response to lithium ion(GO:0010226) |
3.3 | 26.6 | GO:0046958 | learning(GO:0007612) nonassociative learning(GO:0046958) habituation(GO:0046959) |
3.3 | 26.4 | GO:0090594 | inflammatory response to wounding(GO:0090594) |
3.3 | 13.0 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
3.2 | 13.0 | GO:0072116 | kidney rudiment formation(GO:0072003) pronephros formation(GO:0072116) |
3.2 | 38.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
3.2 | 16.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
3.2 | 109.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
3.2 | 19.4 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) positive regulation of glial cell differentiation(GO:0045687) positive regulation of oligodendrocyte differentiation(GO:0048714) |
3.2 | 28.5 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
3.2 | 9.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
3.1 | 12.5 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
3.1 | 12.5 | GO:0015677 | copper ion import(GO:0015677) |
3.1 | 25.0 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
3.1 | 49.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
3.1 | 43.0 | GO:0046883 | regulation of hormone secretion(GO:0046883) |
3.1 | 9.2 | GO:0019695 | choline metabolic process(GO:0019695) |
3.0 | 15.1 | GO:0060055 | endothelial cell chemotaxis(GO:0035767) angiogenesis involved in wound healing(GO:0060055) |
3.0 | 9.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) negative regulation of adherens junction organization(GO:1903392) |
3.0 | 75.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
3.0 | 15.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
3.0 | 11.8 | GO:0019532 | oxalate transport(GO:0019532) |
3.0 | 20.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
2.9 | 20.6 | GO:0070073 | clustering of voltage-gated calcium channels(GO:0070073) |
2.9 | 20.6 | GO:2001270 | negative regulation of execution phase of apoptosis(GO:1900118) regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.9 | 8.7 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
2.9 | 99.9 | GO:0050708 | regulation of protein secretion(GO:0050708) |
2.8 | 5.6 | GO:0048588 | developmental cell growth(GO:0048588) |
2.8 | 56.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
2.8 | 8.4 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
2.8 | 25.1 | GO:0035372 | protein localization to microtubule(GO:0035372) protein localization to microtubule plus-end(GO:1904825) |
2.8 | 22.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
2.7 | 13.6 | GO:0014896 | muscle hypertrophy(GO:0014896) |
2.7 | 16.3 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
2.7 | 8.1 | GO:0010312 | detoxification of zinc ion(GO:0010312) stress response to zinc ion(GO:1990359) |
2.7 | 29.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.7 | 5.4 | GO:0033337 | dorsal fin development(GO:0033337) |
2.7 | 13.5 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
2.7 | 8.0 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
2.6 | 7.9 | GO:0003403 | optic vesicle formation(GO:0003403) |
2.6 | 15.8 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
2.6 | 39.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
2.6 | 7.8 | GO:1990120 | messenger ribonucleoprotein complex assembly(GO:1990120) |
2.6 | 10.3 | GO:0051012 | microtubule sliding(GO:0051012) |
2.6 | 25.7 | GO:0044805 | late nucleophagy(GO:0044805) |
2.6 | 7.7 | GO:0060292 | long term synaptic depression(GO:0060292) |
2.6 | 23.0 | GO:0001964 | startle response(GO:0001964) |
2.6 | 20.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
2.5 | 53.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.5 | 20.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
2.5 | 12.6 | GO:0007624 | ultradian rhythm(GO:0007624) |
2.5 | 9.9 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
2.5 | 19.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.5 | 27.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
2.4 | 24.0 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
2.4 | 43.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
2.4 | 7.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
2.4 | 19.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
2.4 | 47.2 | GO:0097061 | dendritic spine organization(GO:0097061) |
2.3 | 155.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
2.3 | 57.6 | GO:0099645 | protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
2.3 | 11.5 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) |
2.3 | 211.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
2.3 | 22.9 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) |
2.3 | 27.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.3 | 15.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.2 | 15.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
2.2 | 17.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
2.2 | 24.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.2 | 13.3 | GO:0048795 | swim bladder morphogenesis(GO:0048795) |
2.2 | 28.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.2 | 17.6 | GO:0035264 | multicellular organism growth(GO:0035264) |
2.2 | 41.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
2.2 | 10.8 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
2.1 | 32.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
2.1 | 23.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
2.1 | 10.5 | GO:0071881 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway(GO:0071881) |
2.1 | 21.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
2.1 | 6.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.0 | 6.1 | GO:1902571 | regulation of serine-type peptidase activity(GO:1902571) |
2.0 | 18.0 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) |
2.0 | 69.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.0 | 9.9 | GO:0022029 | forebrain cell migration(GO:0021885) telencephalon cell migration(GO:0022029) |
2.0 | 5.9 | GO:1902534 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) single-organism membrane invagination(GO:1902534) |
2.0 | 33.5 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
2.0 | 7.8 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
2.0 | 15.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
2.0 | 462.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.9 | 7.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.9 | 17.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.9 | 11.4 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
1.9 | 33.9 | GO:1902287 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.9 | 11.3 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
1.9 | 22.3 | GO:0042407 | cristae formation(GO:0042407) |
1.8 | 7.4 | GO:0035124 | embryonic caudal fin morphogenesis(GO:0035124) |
1.8 | 5.5 | GO:0035973 | aggrephagy(GO:0035973) |
1.8 | 7.4 | GO:1902042 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
1.8 | 12.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.8 | 51.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.8 | 5.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.8 | 17.7 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
1.8 | 12.3 | GO:0042311 | vasodilation(GO:0042311) |
1.7 | 10.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.7 | 8.7 | GO:0055016 | hypochord development(GO:0055016) |
1.7 | 13.8 | GO:0046323 | glucose import(GO:0046323) |
1.7 | 17.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.7 | 12.0 | GO:0036268 | swimming(GO:0036268) |
1.7 | 17.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.7 | 8.5 | GO:1901909 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.7 | 23.3 | GO:0007622 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
1.7 | 26.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.7 | 33.0 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
1.6 | 26.4 | GO:0036065 | fucosylation(GO:0036065) |
1.6 | 21.4 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
1.6 | 4.9 | GO:1903332 | regulation of protein folding(GO:1903332) positive regulation of protein folding(GO:1903334) regulation of chaperone-mediated protein folding(GO:1903644) positive regulation of chaperone-mediated protein folding(GO:1903646) |
1.6 | 11.3 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
1.6 | 19.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.6 | 38.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
1.6 | 31.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.6 | 31.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.5 | 12.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.5 | 10.6 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
1.5 | 22.7 | GO:0045116 | protein neddylation(GO:0045116) |
1.5 | 10.4 | GO:0099560 | synaptic membrane adhesion(GO:0099560) |
1.5 | 5.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.5 | 39.4 | GO:0048263 | determination of dorsal identity(GO:0048263) |
1.5 | 55.3 | GO:0032400 | melanosome localization(GO:0032400) |
1.5 | 8.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.4 | 11.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.4 | 22.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.4 | 19.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.4 | 2.8 | GO:0048211 | Golgi vesicle docking(GO:0048211) |
1.4 | 22.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
1.4 | 6.9 | GO:0030431 | sleep(GO:0030431) |
1.4 | 9.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.4 | 2.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
1.4 | 5.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.4 | 40.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
1.3 | 5.3 | GO:0050955 | thermoception(GO:0050955) detection of temperature stimulus involved in thermoception(GO:0050960) detection of temperature stimulus involved in sensory perception(GO:0050961) |
1.3 | 18.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
1.3 | 8.0 | GO:0071569 | protein ufmylation(GO:0071569) |
1.3 | 26.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
1.3 | 9.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.3 | 17.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.3 | 7.7 | GO:0000455 | enzyme-directed rRNA pseudouridine synthesis(GO:0000455) |
1.3 | 16.6 | GO:0045851 | vacuolar acidification(GO:0007035) pH reduction(GO:0045851) intracellular pH reduction(GO:0051452) |
1.3 | 6.4 | GO:0003422 | growth plate cartilage morphogenesis(GO:0003422) chondrocyte intercalation involved in growth plate cartilage morphogenesis(GO:0003428) |
1.3 | 3.8 | GO:0008344 | adult locomotory behavior(GO:0008344) |
1.3 | 3.8 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
1.3 | 7.6 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) positive regulation of polyamine transmembrane transport(GO:1902269) |
1.3 | 7.6 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
1.3 | 3.8 | GO:0000338 | protein deneddylation(GO:0000338) |
1.2 | 8.7 | GO:0007634 | optokinetic behavior(GO:0007634) |
1.2 | 11.2 | GO:0015886 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
1.2 | 4.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.2 | 20.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.2 | 23.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
1.2 | 21.7 | GO:0019228 | neuronal action potential(GO:0019228) |
1.2 | 6.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.2 | 13.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.2 | 4.8 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
1.2 | 3.5 | GO:0018872 | arsonoacetate metabolic process(GO:0018872) |
1.2 | 18.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.2 | 3.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
1.2 | 31.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.1 | 8.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
1.1 | 9.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.1 | 7.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.1 | 15.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.1 | 5.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.1 | 13.4 | GO:0039020 | pronephric nephron tubule development(GO:0039020) |
1.1 | 28.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.1 | 40.4 | GO:0036269 | swimming behavior(GO:0036269) |
1.1 | 27.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.1 | 23.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
1.1 | 15.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.1 | 2.2 | GO:0048798 | swim bladder maturation(GO:0048796) swim bladder inflation(GO:0048798) |
1.1 | 21.3 | GO:0015872 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) dopamine transport(GO:0015872) |
1.1 | 3.2 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
1.0 | 42.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
1.0 | 245.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
1.0 | 4.1 | GO:0061709 | reticulophagy(GO:0061709) |
1.0 | 288.5 | GO:0099536 | synaptic signaling(GO:0099536) |
1.0 | 8.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
1.0 | 15.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
1.0 | 8.9 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
1.0 | 20.7 | GO:0007020 | microtubule nucleation(GO:0007020) |
1.0 | 7.9 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) regulation of mast cell activation involved in immune response(GO:0033006) leukocyte degranulation(GO:0043299) regulation of leukocyte degranulation(GO:0043300) mast cell degranulation(GO:0043303) regulation of mast cell degranulation(GO:0043304) |
1.0 | 8.8 | GO:0002690 | mast cell chemotaxis(GO:0002551) positive regulation of leukocyte chemotaxis(GO:0002690) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
1.0 | 2.9 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of sulfur metabolic process(GO:0042762) regulation of homocysteine metabolic process(GO:0050666) |
1.0 | 34.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.0 | 5.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.0 | 27.8 | GO:0021587 | cerebellum morphogenesis(GO:0021587) |
1.0 | 3.8 | GO:0048321 | axial mesoderm formation(GO:0048320) axial mesodermal cell differentiation(GO:0048321) axial mesodermal cell fate commitment(GO:0048322) axial mesodermal cell fate specification(GO:0048327) |
1.0 | 8.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.9 | 4.7 | GO:0032418 | lysosome localization(GO:0032418) |
0.9 | 14.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.9 | 8.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.9 | 3.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.9 | 6.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.9 | 4.6 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.9 | 20.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.9 | 2.8 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.9 | 8.2 | GO:0098789 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.9 | 33.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.9 | 2.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.9 | 4.5 | GO:0030242 | pexophagy(GO:0030242) |
0.9 | 4.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.9 | 9.9 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.9 | 2.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.9 | 2.7 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.9 | 6.2 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.9 | 19.6 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.9 | 6.2 | GO:0097009 | energy homeostasis(GO:0097009) |
0.9 | 13.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 12.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.9 | 7.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.9 | 31.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.9 | 457.5 | GO:0031175 | neuron projection development(GO:0031175) |
0.8 | 11.9 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.8 | 62.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.8 | 6.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.8 | 8.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.8 | 7.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 24.8 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.8 | 3.3 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
0.8 | 10.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.8 | 42.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.8 | 23.4 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.8 | 2.4 | GO:0060765 | androgen receptor signaling pathway(GO:0030521) regulation of androgen receptor signaling pathway(GO:0060765) |
0.8 | 9.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 16.8 | GO:1901214 | regulation of neuron death(GO:1901214) |
0.8 | 3.9 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.8 | 3.1 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.8 | 15.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 7.7 | GO:0006868 | glutamine transport(GO:0006868) |
0.8 | 6.2 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.8 | 9.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.8 | 5.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.8 | 3.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.8 | 1.5 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.7 | 37.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.7 | 3.7 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.7 | 31.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.7 | 13.1 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.7 | 8.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.7 | 3.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.7 | 7.3 | GO:0015800 | acidic amino acid transport(GO:0015800) aspartate transport(GO:0015810) L-glutamate transport(GO:0015813) malate-aspartate shuttle(GO:0043490) |
0.7 | 3.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.7 | 58.0 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.7 | 3.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.7 | 31.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.7 | 11.8 | GO:0021761 | limbic system development(GO:0021761) hypothalamus development(GO:0021854) |
0.7 | 15.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.7 | 114.6 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.7 | 6.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 8.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 11.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.6 | 2.6 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.6 | 1.9 | GO:0009193 | ribonucleoside diphosphate catabolic process(GO:0009191) pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
0.6 | 4.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.6 | 6.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.6 | 53.3 | GO:0072659 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.6 | 12.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.6 | 16.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.6 | 4.3 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.6 | 9.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.6 | 14.9 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.6 | 2.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.6 | 7.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.6 | 8.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.6 | 12.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.6 | 2.4 | GO:0035521 | monoubiquitinated protein deubiquitination(GO:0035520) monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 12.0 | GO:0048634 | regulation of muscle organ development(GO:0048634) |
0.6 | 16.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 7.2 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.6 | 2.4 | GO:0046168 | NADH oxidation(GO:0006116) glycerol-3-phosphate catabolic process(GO:0046168) |
0.6 | 2.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 29.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.6 | 7.7 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.6 | 2.4 | GO:0051645 | Golgi localization(GO:0051645) |
0.6 | 4.7 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.6 | 7.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.6 | 6.4 | GO:0046683 | response to purine-containing compound(GO:0014074) response to ATP(GO:0033198) response to organophosphorus(GO:0046683) |
0.6 | 4.6 | GO:0070654 | sensory epithelium regeneration(GO:0070654) epithelium regeneration(GO:1990399) |
0.6 | 59.9 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.6 | 10.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.6 | 11.5 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.6 | 10.8 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.6 | 9.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.6 | 2.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 7.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.5 | 2.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 7.5 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.5 | 8.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 32.6 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.5 | 3.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centriole replication(GO:0046600) negative regulation of centrosome cycle(GO:0046606) |
0.5 | 1.6 | GO:0050748 | N-terminal protein palmitoylation(GO:0006500) negative regulation of lipoprotein metabolic process(GO:0050748) regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.5 | 11.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.5 | 19.7 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
0.5 | 2.1 | GO:0003400 | regulation of COPII vesicle coating(GO:0003400) regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis(GO:0090113) |
0.5 | 21.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.5 | 5.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.5 | 13.6 | GO:0035118 | embryonic pectoral fin morphogenesis(GO:0035118) |
0.5 | 17.5 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.5 | 3.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.5 | 3.8 | GO:0044211 | CTP salvage(GO:0044211) |
0.5 | 10.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.5 | 26.8 | GO:0003341 | cilium movement(GO:0003341) |
0.5 | 0.9 | GO:1904357 | negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.5 | 5.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.5 | 6.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.5 | 2.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 2.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 6.3 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.4 | 1.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.4 | 1.3 | GO:0010664 | negative regulation of muscle cell apoptotic process(GO:0010656) muscle cell apoptotic process(GO:0010657) striated muscle cell apoptotic process(GO:0010658) regulation of muscle cell apoptotic process(GO:0010660) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.4 | 30.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.4 | 1.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 4.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.4 | 2.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 3.4 | GO:0006566 | threonine metabolic process(GO:0006566) threonine catabolic process(GO:0006567) |
0.4 | 1.7 | GO:0070555 | response to interleukin-1(GO:0070555) cellular response to interleukin-1(GO:0071347) |
0.4 | 18.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.4 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 2.8 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.4 | 9.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 5.8 | GO:0002574 | thrombocyte differentiation(GO:0002574) |
0.4 | 1.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.4 | 3.0 | GO:0021772 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.4 | 32.2 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) internal peptidyl-lysine acetylation(GO:0018393) peptidyl-lysine acetylation(GO:0018394) |
0.4 | 4.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 6.8 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.4 | 2.8 | GO:0006478 | protein sulfation(GO:0006477) peptidyl-tyrosine sulfation(GO:0006478) |
0.3 | 29.6 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.3 | 6.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.3 | 4.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.3 | 17.9 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
0.3 | 43.2 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.3 | 3.0 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.3 | 19.4 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.3 | 5.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 11.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.3 | 4.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 4.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 17.4 | GO:0006476 | protein deacetylation(GO:0006476) |
0.3 | 8.2 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.3 | 2.1 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.3 | 2.1 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.3 | 12.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 1.7 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.3 | 1.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 27.6 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.3 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 9.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 5.9 | GO:0003094 | glomerular filtration(GO:0003094) |
0.3 | 10.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.3 | 9.0 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.3 | 50.0 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.3 | 2.8 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 1.5 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 11.3 | GO:0007338 | single fertilization(GO:0007338) |
0.2 | 12.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.2 | 5.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 1.7 | GO:0072554 | endothelial tube morphogenesis(GO:0061154) blood vessel lumenization(GO:0072554) |
0.2 | 1.6 | GO:0031179 | peptide modification(GO:0031179) |
0.2 | 0.6 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 3.1 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.2 | 5.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 2.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 5.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 6.5 | GO:0034111 | negative regulation of homotypic cell-cell adhesion(GO:0034111) negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.2 | 3.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 1.6 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
0.2 | 1.0 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.2 | 5.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 4.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 7.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.2 | 1.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 3.3 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.2 | 6.2 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.2 | 1.8 | GO:0097178 | ruffle organization(GO:0031529) ruffle assembly(GO:0097178) |
0.1 | 2.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.1 | 1.4 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.6 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.1 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 3.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 1.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 8.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 1.0 | GO:0019430 | response to superoxide(GO:0000303) response to oxygen radical(GO:0000305) removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.1 | 0.4 | GO:0035138 | pectoral fin morphogenesis(GO:0035138) |
0.1 | 1.4 | GO:0032438 | melanosome organization(GO:0032438) |
0.1 | 0.7 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.7 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) |
0.1 | 0.4 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.1 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.4 | GO:0039689 | viral genome replication(GO:0019079) negative stranded viral RNA replication(GO:0039689) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) multi-organism metabolic process(GO:0044033) multi-organism biosynthetic process(GO:0044034) |
0.1 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.9 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 1.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 4.8 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.1 | 2.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 13.5 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 20.1 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.1 | 0.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 1.7 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 1.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 4.0 | GO:0007034 | vacuolar transport(GO:0007034) |
0.1 | 0.9 | GO:0031503 | protein complex localization(GO:0031503) |
0.0 | 0.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.5 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.3 | 109.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
17.4 | 104.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
14.4 | 143.7 | GO:0098982 | GABA-ergic synapse(GO:0098982) |
11.0 | 66.2 | GO:0005955 | calcineurin complex(GO:0005955) |
9.6 | 57.3 | GO:0043083 | synaptic cleft(GO:0043083) |
9.5 | 28.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
8.8 | 35.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
7.5 | 22.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
7.4 | 14.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
7.3 | 7.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
7.1 | 21.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
6.9 | 234.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
6.3 | 278.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
5.8 | 17.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
5.6 | 55.7 | GO:0042583 | chromaffin granule(GO:0042583) |
5.5 | 5.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
4.9 | 59.1 | GO:0044295 | axonal growth cone(GO:0044295) |
4.7 | 198.5 | GO:0030426 | growth cone(GO:0030426) |
4.6 | 346.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
4.6 | 142.8 | GO:0043679 | axon terminus(GO:0043679) neuron projection terminus(GO:0044306) |
4.4 | 88.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
4.3 | 13.0 | GO:0098826 | endoplasmic reticulum tubular network membrane(GO:0098826) |
4.2 | 62.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
4.0 | 31.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
3.8 | 50.0 | GO:1990246 | uniplex complex(GO:1990246) |
3.8 | 91.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
3.3 | 13.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.3 | 23.2 | GO:0043194 | axon initial segment(GO:0043194) |
3.1 | 21.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
3.1 | 49.0 | GO:0031209 | SCAR complex(GO:0031209) |
3.0 | 35.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
2.9 | 23.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
2.9 | 20.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
2.9 | 23.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor heterodimeric complex(GO:0038039) G-protein coupled receptor complex(GO:0097648) |
2.8 | 50.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
2.7 | 2.7 | GO:0071564 | npBAF complex(GO:0071564) |
2.6 | 21.2 | GO:0016586 | RSC complex(GO:0016586) |
2.6 | 23.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
2.6 | 18.2 | GO:0033270 | paranode region of axon(GO:0033270) |
2.6 | 7.8 | GO:0042382 | paraspeckles(GO:0042382) |
2.6 | 10.3 | GO:0008247 | 1-alkyl-2-acetylglycerophosphocholine esterase complex(GO:0008247) |
2.6 | 23.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) stereocilium tip(GO:0032426) |
2.5 | 19.8 | GO:0034464 | BBSome(GO:0034464) |
2.5 | 7.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
2.4 | 16.8 | GO:0033010 | paranodal junction(GO:0033010) |
2.4 | 165.1 | GO:0031201 | SNARE complex(GO:0031201) |
2.3 | 217.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
2.3 | 22.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.2 | 36.8 | GO:0043209 | myelin sheath(GO:0043209) |
2.2 | 8.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
2.2 | 154.9 | GO:0043025 | neuronal cell body(GO:0043025) |
2.1 | 27.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
2.1 | 6.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
2.1 | 40.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
2.1 | 12.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.1 | 128.5 | GO:0034704 | calcium channel complex(GO:0034704) |
2.1 | 6.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.1 | 34.9 | GO:0030008 | TRAPP complex(GO:0030008) |
2.0 | 50.8 | GO:0005921 | gap junction(GO:0005921) |
2.0 | 41.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.0 | 7.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
2.0 | 15.8 | GO:0005614 | interstitial matrix(GO:0005614) |
1.9 | 44.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.9 | 20.4 | GO:0061617 | MICOS complex(GO:0061617) |
1.8 | 9.0 | GO:0008091 | spectrin(GO:0008091) |
1.8 | 113.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.8 | 25.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.8 | 17.9 | GO:0045171 | intercellular bridge(GO:0045171) |
1.8 | 214.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.8 | 31.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.7 | 98.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.6 | 185.1 | GO:0014069 | postsynaptic density(GO:0014069) |
1.6 | 31.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.6 | 45.6 | GO:0098978 | glutamatergic synapse(GO:0098978) |
1.6 | 48.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.6 | 109.0 | GO:0030141 | secretory granule(GO:0030141) |
1.6 | 4.9 | GO:0072380 | TRC complex(GO:0072380) |
1.6 | 35.3 | GO:0043256 | basal lamina(GO:0005605) laminin complex(GO:0043256) |
1.5 | 26.3 | GO:0060170 | ciliary membrane(GO:0060170) |
1.5 | 40.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.5 | 29.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.5 | 7.4 | GO:0070724 | BMP receptor complex(GO:0070724) |
1.5 | 33.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.4 | 17.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.4 | 10.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.4 | 5.5 | GO:0046695 | SLIK (SAGA-like) complex(GO:0046695) |
1.4 | 112.9 | GO:0005871 | kinesin complex(GO:0005871) |
1.3 | 13.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.3 | 3.9 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.3 | 10.4 | GO:0032783 | ELL-EAF complex(GO:0032783) |
1.3 | 551.7 | GO:0043005 | neuron projection(GO:0043005) |
1.3 | 6.4 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
1.3 | 8.9 | GO:0001650 | fibrillar center(GO:0001650) |
1.2 | 15.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.2 | 27.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.2 | 26.9 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.2 | 8.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.2 | 21.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.2 | 4.8 | GO:0097268 | cytoophidium(GO:0097268) |
1.2 | 9.5 | GO:0001401 | mitochondrial sorting and assembly machinery complex(GO:0001401) |
1.2 | 13.0 | GO:0000124 | SAGA complex(GO:0000124) |
1.2 | 5.8 | GO:0071203 | WASH complex(GO:0071203) |
1.1 | 9.1 | GO:0071914 | prominosome(GO:0071914) |
1.1 | 5.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.1 | 6.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.1 | 10.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.1 | 2.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
1.1 | 15.8 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
1.0 | 10.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.0 | 12.4 | GO:0036038 | MKS complex(GO:0036038) |
1.0 | 4.1 | GO:0005880 | nuclear microtubule(GO:0005880) |
1.0 | 3.1 | GO:0031417 | NatC complex(GO:0031417) |
1.0 | 20.0 | GO:0034399 | nuclear periphery(GO:0034399) |
1.0 | 8.0 | GO:0097225 | sperm midpiece(GO:0097225) |
1.0 | 119.1 | GO:0045202 | synapse(GO:0045202) |
1.0 | 31.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.0 | 6.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.0 | 23.4 | GO:0005844 | polysome(GO:0005844) |
0.9 | 2.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.9 | 2.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.8 | 3.4 | GO:0016589 | NURF complex(GO:0016589) |
0.8 | 79.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.8 | 3.3 | GO:0070319 | Golgi to plasma membrane transport vesicle(GO:0070319) |
0.8 | 18.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.8 | 3.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.8 | 3.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 7.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.8 | 10.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 19.2 | GO:0000145 | exocyst(GO:0000145) |
0.7 | 3.5 | GO:0033503 | HULC complex(GO:0033503) |
0.7 | 4.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.7 | 12.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.6 | 5.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.6 | 1.9 | GO:1990879 | CST complex(GO:1990879) |
0.6 | 2.5 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.6 | 3.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.6 | 4.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 9.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.6 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.6 | 7.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 7.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 4.6 | GO:0030670 | endocytic vesicle membrane(GO:0030666) phagocytic vesicle membrane(GO:0030670) |
0.6 | 12.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 7.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.5 | 16.2 | GO:0030286 | dynein complex(GO:0030286) |
0.5 | 1.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 10.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.5 | 14.5 | GO:0000922 | spindle pole(GO:0000922) |
0.5 | 2.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.5 | 2.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.4 | 6.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 24.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 5.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 4.8 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.4 | 1.7 | GO:0097519 | DNA recombinase complex(GO:0097519) |
0.4 | 40.7 | GO:0005770 | late endosome(GO:0005770) |
0.4 | 12.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.4 | 33.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 25.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.4 | 51.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 2.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.4 | 5.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 9.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 7.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.4 | 13.9 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.4 | 8.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 2.4 | GO:0035517 | PR-DUB complex(GO:0035517) |
0.3 | 4.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 2.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 13.7 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.3 | 2.9 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.3 | 11.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 4.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 14.1 | GO:0031514 | motile cilium(GO:0031514) |
0.3 | 64.8 | GO:0005768 | endosome(GO:0005768) |
0.3 | 319.7 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.3 | 13.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.3 | 6.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 3.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 74.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 1.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 22.6 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 2.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 89.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 2.0 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.2 | 1.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 11.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 4.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 12.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 3.0 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 658.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 1.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.2 | GO:0043514 | interleukin-12 complex(GO:0043514) interleukin-23 complex(GO:0070743) |
0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.3 | 99.8 | GO:1903136 | cuprous ion binding(GO:1903136) |
29.3 | 88.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
27.3 | 109.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
18.2 | 273.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
16.3 | 97.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
15.8 | 63.4 | GO:0044548 | S100 protein binding(GO:0044548) |
14.4 | 201.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) GABA-gated chloride ion channel activity(GO:0022851) |
11.4 | 45.5 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
11.0 | 66.2 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
9.7 | 29.1 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
9.7 | 174.5 | GO:0098882 | structural constituent of presynaptic active zone(GO:0098882) |
9.6 | 385.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
9.6 | 28.7 | GO:0038046 | enkephalin receptor activity(GO:0038046) |
8.9 | 35.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
7.5 | 89.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
7.1 | 42.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
6.7 | 26.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
5.8 | 23.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
5.7 | 23.0 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) methylglyoxal synthase activity(GO:0008929) |
4.9 | 14.7 | GO:0042165 | neurotransmitter binding(GO:0042165) acetylcholine binding(GO:0042166) |
4.8 | 24.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
4.8 | 14.4 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
4.6 | 23.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
4.6 | 41.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
4.5 | 58.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
4.5 | 13.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
4.4 | 17.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
4.4 | 21.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
4.3 | 103.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
4.3 | 72.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.1 | 74.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
4.1 | 53.5 | GO:0004111 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
4.1 | 12.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
4.1 | 8.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
4.0 | 28.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
4.0 | 31.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
4.0 | 43.8 | GO:0004309 | exopolyphosphatase activity(GO:0004309) |
3.9 | 35.5 | GO:0004359 | glutaminase activity(GO:0004359) |
3.9 | 189.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
3.9 | 15.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
3.9 | 27.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
3.8 | 23.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
3.8 | 49.1 | GO:0005165 | nerve growth factor receptor binding(GO:0005163) neurotrophin receptor binding(GO:0005165) |
3.8 | 64.1 | GO:0045159 | myosin II binding(GO:0045159) |
3.7 | 51.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
3.7 | 77.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
3.6 | 28.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
3.5 | 14.2 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
3.5 | 31.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
3.4 | 91.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
3.4 | 16.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
3.3 | 9.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
3.3 | 16.5 | GO:0070004 | cysteine-type exopeptidase activity(GO:0070004) |
3.3 | 42.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
3.1 | 62.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
3.1 | 15.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) phosphatidylglycerol binding(GO:1901611) |
3.1 | 12.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
3.1 | 9.4 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) citrate-L-glutamate ligase activity(GO:0072591) |
3.0 | 36.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
3.0 | 9.0 | GO:0016436 | rRNA (uridine) methyltransferase activity(GO:0016436) |
3.0 | 12.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.9 | 26.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
2.9 | 8.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
2.9 | 86.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
2.9 | 23.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.9 | 11.5 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
2.9 | 17.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.8 | 54.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.8 | 14.2 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
2.8 | 45.3 | GO:0048018 | receptor activator activity(GO:0030546) receptor agonist activity(GO:0048018) |
2.8 | 8.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
2.7 | 39.9 | GO:0019211 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
2.6 | 23.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.6 | 44.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.5 | 53.5 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.5 | 42.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
2.5 | 15.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.5 | 12.5 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
2.5 | 22.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
2.5 | 36.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.4 | 7.3 | GO:0052834 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
2.4 | 24.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
2.4 | 7.2 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
2.4 | 9.6 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
2.4 | 9.6 | GO:0000829 | inositol heptakisphosphate kinase activity(GO:0000829) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
2.4 | 7.2 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
2.4 | 12.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.4 | 19.1 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
2.4 | 14.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.4 | 30.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
2.2 | 4.5 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
2.2 | 19.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
2.2 | 83.0 | GO:0030145 | manganese ion binding(GO:0030145) |
2.2 | 15.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.1 | 6.3 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.1 | 56.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
2.1 | 31.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
2.1 | 26.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.0 | 12.3 | GO:0033781 | cholesterol 24-hydroxylase activity(GO:0033781) |
2.0 | 6.1 | GO:0001729 | ceramide kinase activity(GO:0001729) |
2.0 | 57.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
2.0 | 10.2 | GO:0008743 | L-threonine 3-dehydrogenase activity(GO:0008743) |
2.0 | 10.2 | GO:1902387 | ceramide transporter activity(GO:0035620) ceramide 1-phosphate binding(GO:1902387) ceramide 1-phosphate transporter activity(GO:1902388) |
2.0 | 97.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.0 | 6.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
2.0 | 8.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
2.0 | 28.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.0 | 28.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.0 | 26.0 | GO:0030507 | spectrin binding(GO:0030507) |
2.0 | 7.9 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
2.0 | 27.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.9 | 60.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.9 | 32.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.9 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.9 | 5.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.8 | 11.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
1.8 | 11.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.8 | 19.6 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
1.8 | 10.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.8 | 21.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.8 | 42.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.8 | 14.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.8 | 10.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.7 | 34.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
1.7 | 8.5 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
1.7 | 6.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.7 | 33.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.7 | 57.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.6 | 26.3 | GO:0017136 | histone deacetylase activity(GO:0004407) NAD-dependent histone deacetylase activity(GO:0017136) |
1.6 | 25.9 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
1.6 | 19.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.6 | 4.7 | GO:0004061 | arylformamidase activity(GO:0004061) |
1.6 | 14.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
1.5 | 6.2 | GO:0031782 | type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.5 | 23.1 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
1.5 | 50.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.5 | 33.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.5 | 13.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.5 | 47.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
1.5 | 13.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.5 | 13.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.5 | 24.7 | GO:0005272 | sodium channel activity(GO:0005272) |
1.5 | 7.3 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
1.4 | 5.8 | GO:0033745 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) L-methionine-(R)-S-oxide reductase activity(GO:0033745) |
1.4 | 32.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.4 | 18.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.4 | 19.7 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.4 | 21.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.4 | 48.6 | GO:0019003 | GDP binding(GO:0019003) |
1.3 | 144.1 | GO:0005516 | calmodulin binding(GO:0005516) |
1.3 | 8.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.3 | 10.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.3 | 25.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
1.3 | 3.9 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.3 | 6.5 | GO:0004307 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
1.3 | 3.9 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.3 | 5.1 | GO:0017020 | myosin phosphatase regulator activity(GO:0017020) |
1.3 | 7.6 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
1.2 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.2 | 27.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 4.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.2 | 3.5 | GO:0030791 | arsenite methyltransferase activity(GO:0030791) methylarsonite methyltransferase activity(GO:0030792) |
1.2 | 60.0 | GO:0019905 | syntaxin binding(GO:0019905) |
1.2 | 41.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.1 | 4.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.1 | 11.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.1 | 13.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.1 | 8.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.1 | 8.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.1 | 3.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.1 | 7.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.1 | 26.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.1 | 5.4 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
1.1 | 7.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.1 | 7.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.1 | 7.5 | GO:0016918 | retinal binding(GO:0016918) |
1.1 | 35.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.1 | 14.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.0 | 99.7 | GO:0045296 | cadherin binding(GO:0045296) |
1.0 | 23.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
1.0 | 12.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.0 | 23.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
1.0 | 7.8 | GO:0015232 | heme transporter activity(GO:0015232) |
1.0 | 7.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 25.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.9 | 29.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.9 | 6.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.9 | 4.6 | GO:0034595 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.9 | 19.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.9 | 20.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.9 | 281.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.9 | 11.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.9 | 3.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.9 | 1.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.9 | 26.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 5.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.8 | 6.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 2.5 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.8 | 8.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 5.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.8 | 4.9 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.8 | 9.7 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.8 | 8.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.8 | 7.2 | GO:0005113 | patched binding(GO:0005113) |
0.8 | 4.0 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.8 | 31.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.8 | 65.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.8 | 46.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.8 | 17.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.8 | 6.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 3.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.8 | 2.3 | GO:0047690 | aspartyltransferase activity(GO:0047690) |
0.8 | 2.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) tubulin-glycine ligase activity(GO:0070738) |
0.8 | 3.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.8 | 6.8 | GO:0035925 | AU-rich element binding(GO:0017091) mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.8 | 1.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.8 | 5.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.8 | 33.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.7 | 3.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.7 | 14.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.7 | 8.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 18.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 5.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.7 | 17.5 | GO:0031267 | small GTPase binding(GO:0031267) |
0.7 | 7.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 10.9 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.7 | 3.6 | GO:0031841 | neuropeptide Y receptor binding(GO:0031841) type 2 neuropeptide Y receptor binding(GO:0031843) |
0.7 | 4.3 | GO:0043531 | ADP binding(GO:0043531) |
0.7 | 8.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.7 | 11.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.7 | 283.0 | GO:0003712 | transcription factor activity, transcription factor binding(GO:0000989) transcription cofactor activity(GO:0003712) |
0.7 | 64.0 | GO:0022832 | voltage-gated channel activity(GO:0022832) |
0.7 | 4.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.7 | 235.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.7 | 2.0 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.6 | 3.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 9.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.6 | 200.5 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.6 | 8.9 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.6 | 7.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 13.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 7.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.6 | 11.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 24.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 2.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.6 | 3.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.6 | 24.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 2.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.6 | 2.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.6 | 5.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.6 | 2.9 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
0.6 | 18.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 194.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.5 | 11.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.5 | 38.8 | GO:0042802 | identical protein binding(GO:0042802) |
0.5 | 7.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 6.4 | GO:0005231 | extracellular ATP-gated cation channel activity(GO:0004931) excitatory extracellular ligand-gated ion channel activity(GO:0005231) ATP-gated ion channel activity(GO:0035381) |
0.5 | 0.5 | GO:0003994 | aconitate hydratase activity(GO:0003994) |
0.5 | 1.6 | GO:0004788 | thiamine diphosphokinase activity(GO:0004788) thiamine binding(GO:0030975) |
0.5 | 15.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 8.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 8.6 | GO:0002039 | p53 binding(GO:0002039) |
0.5 | 5.3 | GO:0015278 | calcium-release channel activity(GO:0015278) |
0.5 | 14.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.5 | 2.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.5 | 4.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.5 | 11.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.5 | 4.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.5 | 3.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.5 | 0.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 17.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.5 | 3.3 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.5 | 3.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 9.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 12.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.4 | 405.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.4 | 5.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 13.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.4 | 13.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.4 | 18.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.4 | 1.7 | GO:0008488 | gamma-glutamyl carboxylase activity(GO:0008488) |
0.4 | 2.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.4 | 4.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 5.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 4.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 2.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.4 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 2.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 2.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.3 | 5.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 36.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.3 | 2.0 | GO:0004997 | thyrotropin-releasing hormone receptor activity(GO:0004997) |
0.3 | 9.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 16.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.3 | 34.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 3.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 4.8 | GO:0016018 | drug binding(GO:0008144) cyclosporin A binding(GO:0016018) |
0.3 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 1.5 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.3 | 3.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 6.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.5 | GO:1990757 | anaphase-promoting complex binding(GO:0010997) ubiquitin ligase activator activity(GO:1990757) |
0.3 | 2.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 2.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.3 | 3.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 11.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 5.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 4.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 3.0 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.3 | 7.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 1.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 1.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 59.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 108.3 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.2 | 2.6 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 2.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 3.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 1.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.0 | GO:0043560 | insulin-activated receptor activity(GO:0005009) insulin receptor substrate binding(GO:0043560) |
0.2 | 11.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 3.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 1.6 | GO:0036374 | peptidyltransferase activity(GO:0000048) glutathione hydrolase activity(GO:0036374) |
0.2 | 2.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 396.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 8.4 | GO:0000146 | microfilament motor activity(GO:0000146) actin-dependent ATPase activity(GO:0030898) |
0.2 | 3.0 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.2 | 9.0 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 8.0 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 3.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.6 | GO:0017064 | fatty acid amide hydrolase activity(GO:0017064) |
0.1 | 2.1 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 2.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 4.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 3.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 13.0 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 66.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 31.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 2.4 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 0.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 1.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 11.1 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 12.0 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 2.9 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.1 | 0.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 1.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.1 | 2.0 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.9 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 1.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 2.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 12.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0042164 | interleukin-12 binding(GO:0019972) interleukin-12 alpha subunit binding(GO:0042164) |
0.0 | 1.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.8 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 84.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
3.4 | 26.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.1 | 36.8 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
2.2 | 65.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
2.0 | 42.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
2.0 | 44.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.0 | 39.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.9 | 27.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.7 | 74.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.7 | 48.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.7 | 35.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.6 | 12.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.5 | 42.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
1.4 | 13.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.4 | 28.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.3 | 10.6 | PID REELIN PATHWAY | Reelin signaling pathway |
1.3 | 44.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.3 | 17.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.2 | 54.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.1 | 37.2 | PID ATM PATHWAY | ATM pathway |
1.1 | 22.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.0 | 7.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.0 | 24.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.0 | 3.9 | ST ADRENERGIC | Adrenergic Pathway |
1.0 | 15.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.9 | 20.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.9 | 8.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.8 | 18.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.8 | 13.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.8 | 10.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.8 | 12.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 45.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 6.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 2.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.7 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 8.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.7 | 21.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.6 | 26.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 4.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 6.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.6 | 21.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.6 | 7.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.6 | 1.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 13.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 6.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 6.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 6.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 10.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 2.8 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 3.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 3.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.0 | 79.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
13.5 | 202.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
9.9 | 29.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
7.7 | 53.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
5.7 | 51.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
5.7 | 79.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
5.4 | 65.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
5.0 | 5.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
4.4 | 26.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
3.6 | 29.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
3.5 | 38.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.4 | 41.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.2 | 45.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
3.2 | 19.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
3.0 | 27.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
2.6 | 15.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
2.5 | 27.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.4 | 24.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
2.3 | 20.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
2.2 | 21.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.1 | 8.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
2.1 | 33.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.0 | 37.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.9 | 7.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.9 | 21.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.9 | 17.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.9 | 19.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.8 | 37.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.6 | 42.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.6 | 11.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.5 | 14.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.5 | 35.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 44.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.2 | 15.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.1 | 59.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
1.1 | 7.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
1.1 | 35.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.1 | 12.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.0 | 5.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.9 | 2.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.9 | 1.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 28.3 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.8 | 5.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.8 | 57.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.8 | 8.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.8 | 43.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.8 | 12.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.7 | 12.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.7 | 3.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.7 | 12.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 9.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.6 | 2.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.6 | 3.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 26.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.6 | 3.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 20.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 5.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 6.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.5 | 7.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 18.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.5 | 6.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 7.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.5 | 5.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 12.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 12.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 15.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 4.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 32.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.4 | 4.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 40.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 9.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 4.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 4.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 9.1 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.3 | 21.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 13.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 6.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 3.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 5.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 4.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 3.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 12.7 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 1.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 4.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 2.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 3.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 4.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 11.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 5.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 1.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 2.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 6.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 4.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 1.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 6.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 1.0 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |